Natural killer cells show their cancer-fighting worth
Natural killer (NK) cells from umbilical-cord blood show promise as a potentially effective and less side-effect-prone alternative to T-cell therapies for blood cancer treatment. [ more ]
Revolutionary CAR-T cell therapy looks to break through beyond blood cancer
CAR-T cell therapy revolutionizes blood cancer treatment by enhancing T-lymphocytes to combat tumors, with potential for wider application beyond hematological cancers. [ more ]
FDA approves bladder cancer treatment by Culver City company
FDA approved new bladder cancer treatment Anktiva by ImmunityBio, activating immune response in patients who didn't respond to prior therapies. [ more ]
Scientists Found a Way to Supercharge Cancer-Fighting Cells
Bioengineered CAR T cells can be rejuvenated by engineering high levels of a specific protein, resembling stem cells, enhancing cancer-fighting abilities. [ more ]
First UK patients receive experimental messenger RNA cancer therapy
A new trial at Hammersmith hospital in west London is evaluating the safety and effectiveness of mRNA therapy in treating melanoma, lung cancer, and other solid tumors.
mRNA therapy works by presenting tumor markers to the patient's immune system, helping it recognize and fight cancer cells. [ more ]
New Cancer Vaccines Could Treat Some Types of Pancreatic, Colorectal and Other Deadly Forms of the Disease
A new experimental therapeutic vaccine shows promise for people with KRAS-mutated pancreatic or colorectal cancer.
The vaccine delivers tumor-targeting molecules directly into the lymph nodes, activating T cells and showing positive results in a phase 1 trial. [ more ]
Inside the Quest to Reprogram Immune Cells Into An Anti-Aging Remedy
Senescent cells are damaged cells that accumulate in the body and contribute to age-related diseases.
Researchers have genetically engineered T cells to target and eliminate senescent cells, resulting in rejuvenation in aged mice and slower aging in young mice. [ more ]